EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination

Lina Ghandour, Wissam Yaacoub, George F Araj

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.20732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Lina Ghandour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Hauptthemen laut MEDLINE: Health Personnel, Immunoglobulin G, Antibodies, Viral, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study evaluated the durability of humoral and cell-mediated immunity (CMI) post Pfizer vaccination among healthcare workers (HCWs) at a tertiary care center in Lebanon. Methodology: A total of 42 HCWs were enrolled, with their past infection and/or vaccination duration ranging between 2 months and 2 years. Blood samples were tested for COVID CMI and humoral immunity simultaneously. Testing for COVID CMI was done by measuring the interferon gamma-release assay (IGRA) using the QuantiFERON SARS-CoV-2 test, and for COVID humoral immunity using the lateral flow Cellex qSARS-CoV-2 IgG/IgM Rapid Test.

Results

The study group was 69% female and 31% male, aged 22–51 years. SARS-CoV-2 was contracted by 33 (78%) HCWs. Positive COVID humoral IgG and CMI response were found among 35 (83.3%) and 19 (45.2%) HCWs, respectively. Combining the findings for both tests revealed concordant positivity in 35.7%, concordant negativity in 7.1%, Pos IgG – Neg IGRA in 47.6%, and Neg IgG – Pos IGRA in 9.5%.

Conclusions

Generally, no correlation was established between humoral and CMI responses following COVID-19 vaccination. That only 83.3% and 45.2% among the Pfizer-vaccinated HCWs tested positive for COVID humoral and CMI, respectively, prevents substantial conclusions about test reliability for determining immunity status post vaccination. Whether these results are influenced by the specific antigenic epitopes used in the tests or by the potential deterioration of the immune response over time remains to be determined. The incongruity between humoral and CMI responses post-vaccination suggests the need for more comprehensive testing methodologies to assess post-vaccination immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PersonnelImmunoglobulin GAntibodies, ViralCOVID-19Interferon-gamma Release TestsSARS-CoV-2COVID-19 VaccinesHumansAdultFemaleMaleMiddle AgedYoung AdultImmunity, HumoralLebanonImmunity, CellularVaccinationBNT162 Vaccine

Stichwörter der Autor:innen

COVID-19cell-mediated immunityhumoral immunity

Substanzen

Immunoglobulin GAntibodies, ViralCOVID-19 VaccinesBNT162 Vaccine

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Zitieren

APA

Ghandour, L., Yaacoub, W., & Araj, G. F. (2025). Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20732

Vancouver

Ghandour L, Yaacoub W, Araj GF. Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20732

BibTeX
@article{Ghandour2025,
  author = {Ghandour, Lina and Yaacoub, Wissam and Araj, George F},
  title = {Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.20732}
}
Kostenlos starten →